NPSUAM Feneryolu and Etiler Polyclinics provide diagnosis and treatment of psychiatric and neurological diseases. Our adult psychiatric unit treats depression, bipolar affective disorder, schizophrenia, social phobia, panic disorder and other psychiatric illnesses that show signs of mild to moderate severity and can be remotely managed. Our child-adolescent psychiatry unit continues to diagnose and treat the psychiatric symptoms that develop during childhood or first appear in adolescence.
For Detailed Information About NPSUAM: www.npsuam.com
Pervasive developmental disorders, childhood depression and anxiety disorders, attention deficit hyperactivity disorder, learning disorders are some of these. Psychotherapy applications are also being made in our adult and child adolescent units. Our neurology unit maintains the neurological and neuropsychiatric charts in parallel with the structural or functional deterioration of the brain as a business association with our psychiatric unit.
Main Approach in NPSUAM Polyclinics:
What is done in the first application?
Patients who first applied to our psychiatry outpatient clinic (especially those who had previously received treatment but did not benefit, treatment-resistant disease) are evaluated in detail during the diagnosis phase.
Neuropsychological Examination: If the patient is over 65 years old or if the forgetfulness has not been done in the last six months with attention problems; tests that measure high-level brain functions (planning, attention, concentration, memory, etc.) are applied. For this SPM; COG; Dauf; Computerized tests, such as NVLT, or a specific group of tests administered with a face-to-face technique are used that are appropriate for the patient's condition.
Personality Profiling: When necessary and in appropriate cases; tests such as MMPI, Rorschach and so on can be conducted. It can be understood whether the patient has a compelling personality structure that creates intense anxiety or perception and / or impairment of thought, thus leading to impairment of brain function in the secondary process. Findings are used in the treatment process.
Neuromonitoring: If not done within the last six months; Quantitative EEG (QEEG) or volumetric cranial MR examinations can be conducted to examine in detail whether there is any deterioration in the structure or function of the brain. Which imaging technique to use is determined after the neuropsychiatric examination.
Sleep Laboratory: Patients with suspected sleep disturbance or epilepsy may be diagnosed with Polysomnography, EEG recording and 12/24-hour video monitoring all night. The sleep profile of the patient is screened and the relationship with the psychiatric / neurological chart is investigated.
Neurobiochemistry Assessment: If it is not done in the last six months in patients over 65 years old and is deemed necessary at younger ages; vitamins, minerals, amounts of iron in the blood (anemia), blood sugar irregularities which can affect the brain functions by blood and urine analysis; liver and kidney functions; the presence of an infection that affects widespread or brain is investigated.
Neuroendocrine Assessment: If the complaints of the patient (such as weight change, energy loss, palpitations, tremor, memory-attention problems, etc.) raise suspicion for certain diseases, weight measurement should be made to determine the levels of hormones that accompany brain functions such as thyroid, cortisol, prolactin and accompanying psychiatric tables.
Toxicological Screening: For people who use medicines or addictive substances that affect their brain function, these substances are investigated while the person is calm. It is repeated regularly at the beginning of treatment and in follow-ups.
Clinic Pharmacogenetic Assessment Klinik: In patients who use medicines, drug blood levels above treatment values or drug interactions may lead to impaired brain function. To detect this, the blood levels of the drugs used are measured /TDM). The patient's genetic profile is received by further analysis of drug excretion in patients with extremely low or high levels of drug blood levels at the average treatment dose. The obtained treatment is tailored to the individual treatment.
Treatment Plan and Follow-up Process
The treatment plan is concluded by evaluating the results of the examination. The treatment process is initiated by sharing with the patient and his / her relatives. Patients who are proposed to use Psychotherapy (Dynamic Orientation Therapy, Cognitive Behavioral Therapy, EMDR, Hypnosis, Addictive Group Therapies, Neurobiofeedback, REHACOM, Play Therapies in Children) techniques or brain stimulation techniques (eg; TMU), are informed and an application letter is provided. Drug blood level measurement (TDM) is used to monitor drug treatment.